Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas H Graham

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Chemical Biology & Drug Design|February 24, 2006
Cellular analysis of disorazole C and structure-activity relationship of analogs of the natural productPeter Wipf, Thomas H Graham, Andreas Vogt, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 17, 2009
Identifying a resistance determinant for the antimitotic natural products disorazole C1 and A1John S Lazo, Celeste E Reese, Andreas Vogt, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 11, 2008
Microtubule binding and disruption and induction of premature senescence by disorazole C(1)Marni Brisson Tierno, Carolyn A Kitchens, Bethany Petrik, et al.
Bioorganic & Medicinal Chemistry Letters|February 1, 2012
Discovery of aminoheterocycles as potent and brain penetrant prolylcarboxypeptidase inhibitorsZhicai Wu, Cangming Yang, Thomas H Graham, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2012
A new class of prolylcarboxypeptidase inhibitors, part 2: the aminocyclopentanesThomas H Graham, Wensheng Liu, Andreas Verras, et al.
Cell Metabolism|May 1, 2018
DGAT2 Inhibition Alters Aspects of Triglyceride Metabolism in Rodents but Not in Non-human PrimatesDavid G McLaren, Seongah Han, Beth Ann Murphy, et al.
Bioorganic & Medicinal Chemistry Letters|October 26, 2013
Discovery and optimization of orally active cyclohexane-based prolylcarboxypeptidase (PrCP) inhibitorsJohn S Debenham, Thomas H Graham, Andreas Verras, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2012
A new class of prolylcarboxypeptidase inhibitors, part 1: discovery and evaluationThomas H Graham, Wensheng Liu, Andreas Verras, et al.
Bioorganic & Medicinal Chemistry Letters|November 15, 2011
The discovery of non-benzimidazole and brain-penetrant prolylcarboxypeptidase inhibitorsThomas H Graham, Hong C Shen, Wensheng Liu, et al.
Journal of Medicinal Chemistry|December 8, 2022
Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1<i>H</i>-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson's DiseaseDavid A Candito, Vladimir Simov, Anmol Gulati, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Chemical Biology & Drug Design|February 24, 2006
Cellular analysis of disorazole C and structure-activity relationship of analogs of the natural productPeter Wipf, Thomas H Graham, Andreas Vogt, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 17, 2009
Identifying a resistance determinant for the antimitotic natural products disorazole C1 and A1John S Lazo, Celeste E Reese, Andreas Vogt, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 11, 2008
Microtubule binding and disruption and induction of premature senescence by disorazole C(1)Marni Brisson Tierno, Carolyn A Kitchens, Bethany Petrik, et al.
Bioorganic & Medicinal Chemistry Letters|February 1, 2012
Discovery of aminoheterocycles as potent and brain penetrant prolylcarboxypeptidase inhibitorsZhicai Wu, Cangming Yang, Thomas H Graham, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2012
A new class of prolylcarboxypeptidase inhibitors, part 2: the aminocyclopentanesThomas H Graham, Wensheng Liu, Andreas Verras, et al.
Cell Metabolism|May 1, 2018
DGAT2 Inhibition Alters Aspects of Triglyceride Metabolism in Rodents but Not in Non-human PrimatesDavid G McLaren, Seongah Han, Beth Ann Murphy, et al.
Bioorganic & Medicinal Chemistry Letters|October 26, 2013
Discovery and optimization of orally active cyclohexane-based prolylcarboxypeptidase (PrCP) inhibitorsJohn S Debenham, Thomas H Graham, Andreas Verras, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2012
A new class of prolylcarboxypeptidase inhibitors, part 1: discovery and evaluationThomas H Graham, Wensheng Liu, Andreas Verras, et al.
Bioorganic & Medicinal Chemistry Letters|November 15, 2011
The discovery of non-benzimidazole and brain-penetrant prolylcarboxypeptidase inhibitorsThomas H Graham, Hong C Shen, Wensheng Liu, et al.
Journal of Medicinal Chemistry|December 8, 2022
Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1<i>H</i>-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson's DiseaseDavid A Candito, Vladimir Simov, Anmol Gulati, et al.
Pageof 2